MedPath

WILL TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION ON MOTOR AND COGNATIVE PERFORMANC WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER EFFECTIVE

Phase 2
Conditions
Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
Registration Number
CTRI/2024/04/066161
Lead Sponsor
Ravi Nair Physiotherapy College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Children with mild & moderate ADHD.

2.Children with inattentive & hyperactive impulsive.

3.Age group- 6-17years

4.Both genders

5.Children who are able to actively participate in a rehabilitation program, including engagement in physical activities

Exclusion Criteria

1.Recent head injury.

2.Any operative neurological disorder.

3.Musculoskeletal disorder.

4.Multiple gestations.

5.Severe ADHD.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vanderbilt ADHD Diagnostic Parent Rating ScaleTimepoint: baseline data will be taken and data will be analyzed at end of the treatment
Secondary Outcome Measures
NameTimeMethod
. SNAP-IV rating scale <br/ ><br> 2.Child behaviour checklist scoring scale. <br/ ><br>Timepoint: baseline data will be taken and data will be analyzed at end of the treatment
© Copyright 2025. All Rights Reserved by MedPath